Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations

v2.4.0.8
Discontinued Operations
 9 Months Ended
Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations [Text Block]
DISCONTINUED OPERATIONS
On December 29, 2011 the Company entered into an agreement to sell certain assets of our Pharmakon business unit. On July 19, 2010, the Board approved closing the TVG business unit and the Company notified employees and issued a press release to that effect on July 20, 2010. The Consolidated Statements of Comprehensive Loss reflect the presentation of Pharmakon and TVG as discontinued operations in all periods presented.

The table below presents the significant components of Pharmakon's and TVG’s results included in Loss from discontinued operations, net of tax in the Condensed Consolidated Statements of Comprehensive Loss for the three- and nine-month periods ended September 30, 2014 and 2013.
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2014

2013
 
2014
 
2013
Revenue, net
$
—

 
$
—

 
$
—

 
$
—

Loss from discontinued operations, before income tax
(28
)
 
(27
)
 
(114
)
 
(27
)
Provision for income tax
1

 
1

 
4

 
4

Loss from discontinued operations, net of tax
$
(29
)
 
$
(28
)
 
$
(118
)
 
$
(31
)

The major classes of assets and liabilities included in the Condensed Consolidated Balance Sheets for Pharmakon and TVG as of September 30, 2014 and December 31, 2013 are as follows:
 
September 30,
2014
 
December 31,
2013
Current assets
$
—

 
$
—

Non-current assets
150

 
150

Total assets
$
150

 
$
150

Current liabilities
$
365

 
$
405

Non-current liabilities
399

 
619

Total liabilities
$
764

 
$
1,024